Refractory Ewing Sarcoma: Clinical Trials

1 trial for Refractory Ewing Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Refractory Ewing Sarcoma: new trials by email Literature Review of Refractory Ewing Sarcoma trials Research Report on Refractory Ewing Sarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabozantinib With Topotecan-Cyclophosphamide
Cabozantinib, Topotecan, Cyclophosphamide - Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma
Phase 1CompletedDana-Farber Cancer Institute122020-12-232023-02-15

Narrower conditions

Osteosarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Sarcoma (1)

Interventions

Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Topotecan (1)  ·  cabozantinib (1)  ·  pegfilgrastim (1)

Sponsors

Dana-Farber Cancer Institute (1)

Countries

United States (1)

Top investigators

Steven C DuBois, MD (1)